Leukaemia Flashcards

1
Q

describe the epidemiology of the cancer of blood/”white blood”

A

 5% of all cancers are cancers of the blood.

 Blood cancers are the most common cancers in men and women aged 15-24 and the main cause of death in 1-34.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the essential cause of leukaemia?

A

Disease of the bone marrow:
a series of mutations in a single lymphoid or myeloid stem cell (progeny of a pluripotent haematopoietic stem cells)

this leads to the overspill of abnormal cells into circulation

multiple mutations is a requirement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the progeny of myeloid stem cells?

A

1) erythroblasts–>erythroid
2) megakaryoblasts
3) myeloblasts–>granulocytic cells
4) monoblasts–>monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the progeny of lymphoid stem cells?

A

Pre B lymphocyte–> B lineage cancer are 75%

Pre T lymphocyte–> T lineage cancer are 25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does leukaemia differ from typical cancers?

A

usually no solid tumours involved

  • the cells affected in this cancer, normally move constantly around circulation and in and out of tissues
    i. e. behave differently as they don’t have a permeant location like a lot of cancers

abnormal cells start to take over bone marrow cells and circuit freely (overflow) into the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what do normal haematopoietic stem cells do?

A

circulate in the blood and both the stem cells and the cells derived from them can enter tissues, and normal lymphoid stem cells recirculate between tissues and blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the issue with describing leukaemia like standard cancers due to the different behaviour of the cells involved? how are the cancers refer?

A

invasion/metastasis cannot be applied normally
- these cells in leukaemia are meant to be mobile

benign–> chronic
malignant–> acute (aggressive and leads to quick death if left untreated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how can leukaemias be classified?

A

1) chronic or acute
2) myeloid or lymphoid
3) subclass
- lymphoid: B or T lineage
- myeloid: granulocytic, monocytic, erythroid or megakaryocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the main classes of leukaemia?

A
o ALL 
– Acute Lymphoblastic Leukaemia.
o AML
 – Acute Myeloid Leukaemia.
o CLL 
– Chronic Lymphocytic Leukaemia.
o CML 
– Chronic Myeloid Leukaemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the important influences that contribute to the pathogenesis of leukaemia?

A
a series of mutations in a single stem cell:
o Proto-oncogene mutations.
o Novel gene creation 
– e.g. a chimeric or fusion gene.
o Dysregulation of a gene 
– when translocation brings the gene under the influence of a promotor or enhancer of another gene.
o TSG loss of function 
– deletion or mutation of both copies.

in those with tendency to have chromosomal breaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the inherited causes contributing to leukaemogenesis?

A

o Down’s syndrome.
o Chromosomal fragility syndromes.
o Defects in DNA repair.
o Inherited defects of TSGs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the environmental causes of mutation?

A
  • Irradiation
  • Anti-cancer drugs.
  • Cigarette smoking.
  • Chemicals – e.g. benzene.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what happens to cells in ACUTE leukaemias?
what is the cause often?
what do mutations usually affect?

A
  • Cell continue to proliferate but they do not mature
  • Often is due to the product of an oncogene affecting proteins
  • mutations usually affect transcription factors that affect multiple genes in a dominant manner
  • affect the ability of the cell to mature

remember that oncogenes tend to cause non-solid tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the consequence of cells not maturing but proliferating in AML?

A

 Build-up of immature cells in BM and this overflows into the blood
 Failure of production of normal functioning end cells such as neutrophils, monocytes, platelets, etc which are replaced by the leukaemic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does CML differ to AML?

A

In CML responsible mutations usually affect genes encoding proteins involved in the signalling pathways from receptors (membrane receptor or cytoplasmic proteins) cml

In AML its transcription factors that are affected (further downstream to signalling pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens to cells in CML?

A

Cell kinetics & function are not as seriously affected as in AML.

  • however the cell becomes independent of external signals i.e. doesnt need GF anymore,
  • there are alterations in the interaction with stroma (signalling affected)
  • there is reduced apoptosis so that cells survive longer and the leukaemic clone expands progressively
  • maturation however still occurs, in CML they are functional

key point: signalling defect and reduced apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the essential difference between AML and CML in terms of end product?

A

AML = failure of production of cells, reduced end product

CML = failure to apoptose, increased production of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the essential difference between ALL and CLL?

A
  • Acute lymphoblastic leukaemia (ALL): Increase in very immature cells (lymphoblasts) with a failure of these to develop to mature B/T cells.
  • Chronic lymphoid leukaemia (CLL): Leukaemic cells are mature but abnormal.

similar to myeloid leukaemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what does the accumulation of abnormal cells lead to in leukaemia?

A
  • Leucocytosis
  • bone pain (acute - in children especially)
  • hepatomegaly
  • splenomegaly (megalies due to free movement of these cells)
  • lymphadenopathy (if lymphoid)
  • thymus enlargement (if T lymphoid)
  • skin infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the metabolic effects of leukaemia cell proliferation?

A
  • Hyperuricemia and renal failure
  • weight loss (metabolism redirection elsewhere)
  • low-grade pyrexia
  • hidrosis (sweating)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

in which group of people is ALL most prevalent?

A

children

highest incidence at age 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what does B-cell lineage ALL result from?

A

delayed exposure to common pathogen
(conversely, early exposure to a pathogen protects)

uncommon causes: (i) irradiation or exposure to chemicals in utero and (ii) mutagenic drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what factors affect exposure to common pathogens which then affects the chance of developing B cell lineage ALL?

A

factors such as family size, new towns, socio-economic class, early social interactions and variations between countries affect the exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is lost in CLL?

A

normal immune function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what can some leukaemias in children result from?

A
o	Irradiation in utero.
o	In utero exposure to certain chemicals
 – Baygon, Dipyrone.
o	EBV.
o	Rarely 
– exposure to a mutagenic drug.
26
Q

what are the two main cellular changes that occur in ALL?

A

accumulation of abnormal cells

crowding out of normal cells

27
Q

what are the clinical features of ALL as a result of the accumulation of abnormal cells (direct effects due to proliferation)?

A
o Bone pain.
o Hepatomegaly
o Splenomegaly.
o Lymphadenopathy.
o Thymic enlargement.
o Testicular enlargement (due to lymphoblastic infiltration)
28
Q

what are the clinical features of ALL as a result of crowding out of normal cells (indirect effects due to replacement)?

A

o Anaemia
– fatigue, lethargy, pallor, dyspnoea, SOB
o Neutropenia
– fever and features of infection e.g. cough
o Thrombocytopenia
– bruising, petechiae, bleeding.

29
Q

what are the haematological features of ALL?

A

o Leucocytosis with lymphoblasts in the blood.
o Anaemia (normocytic, normochromic).
o Neutropenia.
o Thrombocytopenia (low platelets)
o Lymphoblasts replacing normal bone marrow cells

30
Q

what are the investigations that can be done in ALL?

A

o FBC with liver and renal function tests.
o Bone marrow aspirate.
o Cytogenic/molecular analysis.
o Chest x-ray.
o immunophenotyping (to confirm T or B lymphoid cells),

31
Q

what is done in cytogenic analysis (on BM aspirate for example)?

A

Immunophenotyping
– find the lineage of the cells.

methods assess the prognosis of ALL so treatment can be determined depending on the genetic mechanism involved:
• Hyperdiploidy (many extra chromosomes) –>good prognosis.
• T(4; 11) –> poor prognosis.

32
Q

what is the leukaemogenic mechanism in ALL?

A

o Formation of a fusion gene – ETV6-RUNX1.
o Dysregulation of a proto-oncogene
– TCL3 and TCRA.
o Point mutation in a proto-oncogene.

Only one of the fusion genes created in a reciprocal translocation will contribute to leukaemogenesis

33
Q

how can the fusion gene ETV6-RUNX1 be detected using cytogenic and molecular analysis?

A

FISH
o Green probe for ETV6 and red for RUNX1.
o Fused colours give yellow.

34
Q

give an example of where dysregulation occurs?

A

(10; 14) (q24; q11) – the TCL3 gene is dysregulated by proximity to the TCRA gene.

35
Q

what are the 3 types of treatment involved in ALL?

A

1) supportive: blood products (red cells, platelets) to correct the effects of bone marrow failure
2) systemic chemotherapy (widespread disease): to kill off the cells of the leukaemic clone and permit normal cells to regenerate
3) intrathecal chemotherapy: to destroy small numbers of leukaemic cells in the cerebrospinal fluid

in poor prognosis cases, bone marrow (or other haemopoietic stem cell) transplantation may be needed.

36
Q

what is involved in supportive treatment?

A

replace:

  • red cells (anaemia)
  • platelets (thrombocytopenia)
  • antibodies and Antibiotics (infection due to neutropenia)

to address the effects of leukaemia cells replacing normal cells

37
Q

how is intrathecal chemotherapy done?

A

Lumbar puncture done to inject chemotherapy into CSF

instead a high dose of drug capable of crossing the BBB can be given

38
Q

why must treatment be systemic in most cases of leukaemia?

A

the disease becomes widespread very early

39
Q

describe the survival rates in ALL treatment

A

 Childhood ALL survival rates have been increasing gradually (75% can be cured)
 Overall survival has been gradually been getting better:
Approx. 10-year survival was 10% in 60s, now it is 95%.
 Event free survival shows a similar pattern -5%.

40
Q

Leukaemia is not often a solid tumour… what is it ?

A

replacement of normal bone marrow cells with leukaemia cells

41
Q

how common in leukaemia?

A

most common cancer in men and women aged 15-24 (young)

main cancer to cause death in those aged 1-34

42
Q

how does chronic leukaemia behave?

A

they behave in a “benign” way

not aggressive/invasive
you can’t call it benign as there is no solid tumour

43
Q

how does acute leukaemia behave?

A

they have in a “malignant” way

aggressive/invasive
you can’t call it malignant as there is no solid tumour

44
Q

what is the precursor to granulocytes, monocytes, erythroid and megakaryocytes?

A

myeloid

45
Q

why is acute lymphoblastic leukaemia (ALL) “lymphoblastic”?

A

the lymphoblasts can’t mature into B and T lymphocytes

46
Q

what occurs in acute myeloid leukaemia?

A
  • cells proliferate but don’t mature
  • this means only few end cells exist
    end cells= neutrophils, RBCs etc
  • usually a mutation of a transcription factor affecting multiple genes
47
Q

what occurs in chronic myeloid leukaemia?

A
  • opposite to AML as there are TOO many end cells
  • this is due to reduced apoptosis
  • cells have become independent of external signals
  • mutation of a gene involved in signalling pathway eg. membrane receptor
48
Q

what sort of mutation leads to AML?

A

mutation of a transcription factor affecting many genes

49
Q

what sort of mutation leads to CML?

A

mutation of gene involved in signalling pathway e.g. membrane receptor or cytoplasmic protein

explains why apoptosis is reduced

50
Q

level of mature cells in AML

A

low

51
Q

level of mature cells in CML

A

high

52
Q

describe the cell is CLL?

A

they are increased mature B and T cells but abnormal

53
Q

which genetic features provide a good prognosis for ALL?

A

1) Hyperdiploidy

2) t(12;21)

54
Q

what is hyperdiploidy?

A

extra copies of multiple chromosomes

provides a good prognosis

55
Q

why must be FISH uses to look for a t(12;21)?

A

they resultant chromosome does not look any different

t(12:21) produces a good prognosis for ALL
trisomy 4 has the best good prognosis too

56
Q

what genetic features leads to a poor prognosis of ALL?

A

t(4;11)

57
Q

what physiological effects i.e. clinical features does crowding out normal cells in ALL have?

A

These are the effects of replacing normal cells with leukaemia cells:

  • fatigue, lethargy, pallor, breathlessness [anaemia]
  • fever, infection symptoms [neutropenia]
  • bruising, petechiae, bleeding [thrombocytopenia]
58
Q

what 2 things cause the signs and symptoms of leukaemia?

A

(i) proliferation of abnormal cells:
e. g. bone pain, hepatomegaly, splenomegaly and lymphadenopathy (the latter mainly in lymphoid leukaemias).

(ii) loss of function of normal tissues as a result of replacement by leukaemic cells:
e. g. loss of bone marrow function leading to anaemia, thrombocytopenia, neutropenia.

59
Q

difference in CML and CLL?

A

CML produces functional end cells

CLL produces useless end cells (which then replace normal cell)

60
Q

what oncogenic events gives rise to the leukaemic clone in ALL?

A

(i) formation of a fusion gene
(ii) juxtaposition to the promoter of a different gene
(iii) dysregulation of a gene by juxtaposition to enhancers of T-cell receptor genes.

net result is that a clone of cells continues to proliferate but cells do not mature or die. The clone thus expands progressively, replacing normal cells.

61
Q

what are the effects of leukaemic clone expansion in ALL?

A

(i) The direct effects of the proliferation of the leukaemic cells:
(lymphadenopathy, hepatomegaly, splenomegaly, thymic enlargement (T-lineage ALL), bone pain, renal enlargement, testicular enlargement, cranial nerve palsies (meningeal infiltration), hyperuricaemia.

(ii) The indirect effect of leukaemic cell proliferation:
leads to replacement of normal bone marrow cells by leukaemic cells
(causing anaemia, thrombocytopenia, neutropenia).

62
Q

what is thymus enlargement a sign of?

A

T cell lineage ALL